Silco Pharmaceuticals Limited (DSE: SILCOPHL)
Bangladesh
· Delayed Price · Currency is BDT
16.70
+0.10 (0.60%)
At close: Dec 19, 2024
Silco Pharmaceuticals Statistics
Total Valuation
Silco Pharmaceuticals has a market cap or net worth of BDT 1.73 billion. The enterprise value is 1.71 billion.
Market Cap | 1.73B |
Enterprise Value | 1.71B |
Important Dates
The last earnings date was Thursday, December 5, 2024.
Earnings Date | Dec 5, 2024 |
Ex-Dividend Date | Dec 9, 2024 |
Share Statistics
Silco Pharmaceuticals has 103.81 million shares outstanding. The number of shares has decreased by -2.81% in one year.
Current Share Class | n/a |
Shares Outstanding | 103.81M |
Shares Change (YoY) | -2.81% |
Shares Change (QoQ) | -5.67% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 0.71 |
P/TBV Ratio | 0.73 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.43, with a Debt / Equity ratio of 0.00.
Current Ratio | 3.43 |
Quick Ratio | 1.50 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | 311 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.63% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -28.63% |
50-Day Moving Average | 17.05 |
200-Day Moving Average | 18.80 |
Relative Strength Index (RSI) | 49.29 |
Average Volume (20 Days) | 513,388 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | n/a |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 28.78 million in cash and 8.46 million in debt, giving a net cash position of 20.32 million or 0.20 per share.
Cash & Cash Equivalents | 28.78M |
Total Debt | 8.46M |
Net Cash | 20.32M |
Net Cash Per Share | 0.20 |
Equity (Book Value) | 2.37B |
Book Value Per Share | 23.50 |
Working Capital | 760.33M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.60%.
Dividend Per Share | 0.10 |
Dividend Yield | 0.60% |
Dividend Growth (YoY) | -66.67% |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 2.81% |
Shareholder Yield | 3.40% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on November 20, 2019. It was a forward split with a ratio of 1.1.
Last Split Date | Nov 20, 2019 |
Split Type | Forward |
Split Ratio | 1.1 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |